The Evaluation of Otilonium Bromide Treatment in Asian Patients With Irritable Bowel Syndrome

This publication has 38 references indexed in Scilit:

• Effect of otilonium bromide and ibodutant on the internalization of the NK2 receptor in human colon
  Neurogastroenterology & Motility, 2010
• Meta‐analysis: factors affecting placebo response rate in the irritable bowel syndrome
  Alimentary Pharmacology & Therapeutics, 2010
• T-type Ca²⁺channel modulation by otilonium bromide
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
• Asian Motility Studies in Irritable Bowel Syndrome
  Journal of Neurogastroenterology and Motility, 2010
• A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome
  World Journal of Gastroenterology, 2010
• Current and novel therapeutic options for irritable bowel syndrome management
  Digestive and Liver Disease, 2009
• Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis
  BMJ, 2008
• Gender difference on the symptoms, health‐seeking behaviour, social impact and sleep quality in irritable bowel syndrome: a Rome II‐based survey in an apparent healthy adult Chinese population in Taiwan
  Alimentary Pharmacology & Therapeutics, 2005
• The colon-selective spasmolytic otilonium bromide inhibits muscarinic M₃receptor-coupled calcium signals in isolated human colonic crypts
  British Journal of Pharmacology, 2002
• Otilonium bromide in irritable bowel syndrome: a double‐blind, placebo‐controlled, 15‐week study
  Alimentary Pharmacology & Therapeutics, 1998